PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
IPRV.L vs. CD1.AX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

IPRV.L vs. CD1.AX

Last updated Jun 5, 2026

IPRV.L (iShares Listed Private Equity UCITS ETF USD (Dist)) is Financials Equities fund tracking the S&P Listed Private Equity Index, while CD1.AX (CD Private Equity Fund I) is a stock. Over the past 10 years, IPRV.L returned 12.65%/yr vs 18.88%/yr for CD1.AX. At a 0.15 correlation, their price movements are largely independent.

Performance

IPRV.L vs. CD1.AX - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in iShares Listed Private Equity UCITS ETF USD (Dist) (IPRV.L) and CD Private Equity Fund I (CD1.AX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

IPRV.L is traded in GBp, while CD1.AX is traded in AUD. To make them comparable, the CD1.AX values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, IPRV.L achieves a -12.08% return, which is significantly lower than CD1.AX's -5.95% return. Over the past 10 years, IPRV.L has underperformed CD1.AX with an annualized return of 12.65%, while CD1.AX has yielded a comparatively higher 18.88% annualized return.

IPRV.L

1D
2.62%
1M
-2.90%
YTD
-12.08%
6M
-10.54%
1Y
-7.71%
3Y*
10.33%
5Y*
6.33%
10Y*
12.65%

CD1.AX

1D
7.77%
1M
-5.57%
YTD
-5.95%
6M
-13.66%
1Y
0.59%
3Y*
5.66%
5Y*
16.16%
10Y*
18.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IPRV.L vs. CD1.AX - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
IPRV.L
iShares Listed Private Equity UCITS ETF USD (Dist)		-12.08%-4.65%26.96%32.91%-19.32%45.11%2.39%40.72%-7.63%15.66%
CD1.AX
CD Private Equity Fund I		-5.95%28.20%-14.92%23.96%-15.08%161.17%16.67%10.69%15.78%10.49%

Correlation

The correlation between IPRV.L and CD1.AX is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (10Y)
Calculated over the trailing 10-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Aug 14, 2012

0.15

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

iShares Listed Private Equity UCITS ETF USD (Dist)

CD Private Equity Fund I

Often compared with IPRV.L:
IPRV.L vs. SPYIPRV.L vs. QQQ3.LIPRV.L vs. IWMO.LIPRV.L vs. BRK-BIPRV.L vs. BXIPRV.L vs. SWDA.LIPRV.L vs. HMWO.L

Return for Risk

IPRV.L vs. CD1.AX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
IPRV.L
IPRV.L Risk / Return Rank: 66
Overall Rank
IPRV.L Sharpe Ratio Rank: 55
Sharpe Ratio Rank
IPRV.L Sortino Ratio Rank: 55
Sortino Ratio Rank
IPRV.L Omega Ratio Rank: 55
Omega Ratio Rank
IPRV.L Calmar Ratio Rank: 66
Calmar Ratio Rank
IPRV.L Martin Ratio Rank: 66
Martin Ratio Rank
CD1.AX
CD1.AX Risk / Return Rank: 2828
Overall Rank
CD1.AX Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
CD1.AX Sortino Ratio Rank: 2626
Sortino Ratio Rank
CD1.AX Omega Ratio Rank: 2626
Omega Ratio Rank
CD1.AX Calmar Ratio Rank: 3232
Calmar Ratio Rank
CD1.AX Martin Ratio Rank: 2626
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IPRV.L vs. CD1.AX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Listed Private Equity UCITS ETF USD (Dist) (IPRV.L) and CD Private Equity Fund I (CD1.AX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

IPRV.LCD1.AXDifference
Sharpe ratioReturn per unit of total volatility
-0.41
0.02

-0.42

Sortino ratioReturn per unit of downside risk
-0.45
0.28

-0.73

Omega ratioGain probability vs. loss probability

0.95

1.04

-0.09

Calmar ratioReturn relative to maximum drawdown

-0.33

0.02

-0.35

Martin ratioReturn relative to average drawdown

-0.69

0.06

-0.75

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

IPRV.L vs. CD1.AX - Sharpe Ratio Comparison

The current IPRV.L Sharpe Ratio is -0.41, which is lower than the CD1.AX Sharpe Ratio of 0.02. The chart below compares the historical Sharpe Ratios of IPRV.L and CD1.AX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Sharpe Ratios by Period

IPRV.LCD1.AXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.41

0.02

-0.42

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.32

0.41

-0.08

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.62

0.41

+0.21

Sharpe Ratio (All Time)

Calculated using the full available price history

0.16

0.32

-0.16

Drawdowns

IPRV.L vs. CD1.AX - Drawdown Comparison

The maximum IPRV.L drawdown since its inception was -74.08%, which is greater than CD1.AX's maximum drawdown of -56.24%. Use the drawdown chart below to compare losses from any high point for IPRV.L and CD1.AX.

Loading charts...

Drawdown Indicators

IPRV.LCD1.AXDifference

Max Drawdown

Largest peak-to-trough decline

-74.08%

-56.24%

-17.84%

Max Drawdown (1Y)

Largest decline over 1 year

-23.47%

-27.15%

+3.68%

Max Drawdown (3Y)

Largest decline over 3 years

-27.90%

-27.15%

-0.75%

Max Drawdown (5Y)

Largest decline over 5 years

-27.90%

-31.45%

+3.55%

Max Drawdown (10Y)

Largest decline over 10 years

-44.53%

-56.24%

+11.71%

Current Drawdown

Current decline from peak

-22.45%

-21.49%

-0.96%

Average Drawdown

Average peak-to-trough decline

-11.64%

-13.23%

+1.59%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.08%

9.71%

+1.37%

Volatility

IPRV.L vs. CD1.AX - Volatility Comparison

The current volatility for iShares Listed Private Equity UCITS ETF USD (Dist) (IPRV.L) is 5.75%, while CD Private Equity Fund I (CD1.AX) has a volatility of 13.17%. This indicates that IPRV.L experiences smaller price fluctuations and is considered to be less risky than CD1.AX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

IPRV.LCD1.AXDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.75%

13.17%

-7.42%

Volatility (6M)

Calculated over the trailing 6-month period

15.11%

24.96%

-9.85%

Volatility (1Y)

Calculated over the trailing 1-year period

18.90%

34.21%

-15.31%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.52%

39.41%

-19.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

20.36%

46.01%

-25.65%

Dividends

IPRV.L vs. CD1.AX - Dividend Comparison

IPRV.L's dividend yield for the trailing twelve months is around 5.23%, less than CD1.AX's 56.23% yield.

PositionTTM20252024202320222021202020192018201720162015
CD1.AX
CD Private Equity Fund I		56.23%74.03%12.20%38.30%27.12%80.14%55.35%22.58%26.47%36.11%13.18%0.00%
IPRV.L
iShares Listed Private Equity UCITS ETF USD (Dist)		5.23%3.98%3.81%4.27%5.26%3.42%4.85%4.28%6.46%6.70%5.33%8.21%

Frequently Asked Questions

IPRV.L and CD1.AX have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for IPRV.L and CD1.AX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer